EGFR and colorectal carcinoma: Patients with left-sided CRC showed more response to “5-fluorouracil (5-FU)-based regimes” as one of the adjuvant chemotherapies and also to “anti-epidermal growth factor receptor therapy” as targeted therapy with a better prognosis.